HOME >> BIOLOGY >> NEWS
Genetic variants put some patients at risk for particular drug reactions

Genetic variants in the human enzyme that metabolizes the drug warfarin, the frequently prescribed anticoagulant Coumadin, make some patients more susceptible to serious or life-threatening bleeding.

In an article in the April 3, 2002, edition of the Journal of the American Medical Association, Dr. David Veenstra, assistant professor in the University of Washington School of Pharmacy, and his colleagues say that the two genetic variants, CYP2C9*2 and CTP2C9*3, are relatively common. This is one of the first studies to show an association between genetic variants and the risk of a serious adverse drug reaction.

The patients in the retrospective cohort study attended one of two anticoagulation clinics in the Seattle area and received warfarin to prevent blood clotting due to conditions such as atrial fibrillation (irregular heart rhythm).

"After we identified these patients' genotypes, we looked back at their medical records to determine if they had had severe bleeding incidents while they were taking warfarin," Veenstra said. "We looked at two specific variants in the gene for the enzyme that helps patients metabolize warfarin."

Compared to other patients, those with at least one of the genetic variants required more time to achieve stable dosing. In other words, it took a longer period of time to determine an effective and safe dose.

Additionally, patients with at least one of the two genetic variants had a significantly increased occurrence of a serious or life-threatening bleeding incident. Veenstra says that the small numbers of patients (58) with the genetic variants in the 185-person study group suggests caution in interpreting the study's results -- but that screening for these variants may allow clinicians to develop dosing protocols and surveillance techniques to reduce the risk of adverse drug reactions in warfarin patients.

"Warfarin is a very important drug for preventing blood clo
'"/>

Contact: Walter Neary
wneary@u.washington.edu
206-685-3841
University of Washington
2-Apr-2002


Page: 1 2

Related biology news :

1. Genetic mutations linked to the practice of burning coal in homes in China
2. Genetic differences might help distinguish thyroid cancers
3. Genetic modification of linseed produces healthier omega 3 and 6 fatty acids
4. Wiley publishes Welcome to the Genome: A Users Guide to the Genetic Past, Present, and Future
5. Genetically modified bacterium as remedy for intestinal diseases
6. Genetic analysis rewrites salamanders evolutionary history
7. Genetic map of important tree genes outlined
8. Genetically-engineered marathon mouse keeps on running
9. Genetic clues found for common congenital brain disorder
10. Genetic mutation linked to more aggressive breast cancer found more often in African-Americans
11. Genetic discovery could dramatically reduce need for liver transplants in children

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:11/13/2018)... ... 13, 2018 , ... Fluence Bioengineering today unveiled the new ... is well suited for sole-source and supplemental lighting applications addressing virtually every cultivation ... an all-purpose light which can be adapted to virtually any setting, VYPR 2 ...
(Date:11/13/2018)... ... 2018 , ... Board-certified periodontist Dr. Jin Y. Kim, with two locations in ... Santa Ana, CA and surrounding areas, who want to explore permanent, long-term replacement options ... regularly helps patients get the advantages that come with All-on-4® dental implants ...
(Date:11/9/2018)... (PRWEB) , ... November 08, 2018 , ... ... advanced touch screen control. Heating blocks, also known as dry bath incubators are ... of tubes and containers. , For the new heating blocks, Boekel Scientific ...
Breaking Biology News(10 mins):
(Date:11/6/2018)... ... November 06, 2018 , ... ... for clinical trial data collection and management. TrialKit ™, an eClinical platform, ... generation devices can quickly and easily sign in to the app via facial ...
(Date:11/3/2018)... ... November 01, 2018 , ... Come to ... Jean Mulinde, Senior Advisor, Division of Clinical Compliance Evaluation, CDER, FDA will be ... data reliability. , What should clinical research industry stakeholders keep in mind when ...
(Date:10/31/2018)... ... October 30, 2018 , ... The assessment ... very important aspect of experimental biology. Reproducibility of cell-based assays is one of ... choosing the appropriate assay type, there are many more factors to be considered ...
(Date:10/24/2018)... ... 22, 2018 , ... uBiome, the leader in microbial genomics, ... Institute, Stephenson Chair of Data Science, and Professor in the Department of Biomedical ... scientists and doctors from around the world, Dr. Bourne will bring to uBiome ...
Breaking Biology Technology:
Cached News: